Business Description
Harmony Biosciences Holdings is a pharmaceutical company based in Plymouth Meeting, Pennsylvania, focused on treating rare neurological conditions. Its flagship product, WAKIX, is an approved treatment for excessive daytime sleepiness in adults with narcolepsy, while its broader pipeline targets conditions such as Prader-Willi Syndrome, Fragile X Syndrome, Dravet Syndrome, and epilepsy. The company is advancing multiple drug candidates through clinical trials, including orexin receptor agonists and other compounds aimed at sleep disorders and seizure-related conditions. Founded in 2017, Harmony Biosciences serves patients across the United States who have limited treatment options for these complex and often underserved diseases.
